ライフサイエンスコーパス: plasmid DNA

1 y when it is tested against the real target (plasmid DNA).

2 wer for the attenuated DNA and close for the plasmid DNA.

3 asmid DNA and per 10(8) cells with a 13.8 kb plasmid DNA.

4 m minicircles was 5-10-fold higher than with plasmid DNA.

5 st defense by interfering with the uptake of plasmid DNA.

6 (HFFs) infected with HSV or transfected with plasmid DNA.

7 and influencing intracellular trafficking of plasmid DNA.

8 264.7 and DC 2.4 cells using GFP-expressing plasmid DNA.

9 omplexes with a high packaging efficiency of plasmid DNA.

10 idge between PEGylated anionic liposomes and plasmid DNA.

11 d ssDNA and stabilize negative supercoils in plasmid DNA.

12 to target PCR-derived linear double-stranded plasmid DNA.

13 immune responses following immunization with plasmid DNA.

14 key phosphorylation site involved in DNA-PK) plasmid DNA.

15 a novel eukaryotic alternative to bacterial plasmid DNA.

16 mited by detection of contaminating viral or plasmid DNA.

17 rocapsule position on cell transfection with plasmid DNA.

18 plexes formed using BFDMA and macromolecular plasmid DNA.

19 crA helicase to bind and begin unwinding the plasmid DNA.

20 lear membrane to advance nuclear delivery of plasmid DNA.

21 ed muscles over muscles treated with "naked" plasmid DNA.

22 nse than intramuscular injection of the same plasmid DNA.

23 and DNA nodes, within negatively supercoiled plasmid DNA.

24 in vivo and in human genomic DNA spiked with plasmid DNA.

25 iates at multiple single-stranded regions of plasmid DNA.

26 DNA preparations are contaminated with XMRV plasmid DNA.

27 cles (VLPs) when expressed individually from plasmid DNA.

28 tion of 12 novel DeltaG rabies variants from plasmid DNA.

29 rotinin that they nick supercoiled, circular plasmid DNA.

30 the faithful replication of chromosomal and plasmid DNA.

31 e local microbubble-enhanced sonoporation of plasmid DNA.

32 n health, often residing in extrachromosomal plasmid DNA.

33 ved 20% 5-gmC in the genome and 45% 5-gmC in plasmid DNA.

34 These studies were done with plasmid DNA (~2.6 kilobase (kb)) in JM109 E. coli cells.

35 issue, we used intradermal immunization with plasmid DNA, a system in which activation of CD8(+) T ce

36 ticles or by intramuscular immunization with plasmid DNA alone.

37 und that mice injected with 50mug luciferase plasmid DNA and 5x10(5) microbubbles followed by ultraso

38 as detected, but only in animals primed with plasmid DNA and boosted with trimeric protein.

39 caused restriction of incoming bacteriophage/plasmid DNA and endogenous chromosomal DNA within Escher

40 cationic polymers and fluorescently labeled plasmid DNA and injected them intradermally into mice.

41 to consistently enhance the delivery of both plasmid DNA and messenger RNA payloads in stem cells, pr

42 formation efficiency up to 10(7) CFU per mug plasmid DNA and per 10(8) cells with a 13.8 kb plasmid D

43 The peptides protected plasmid DNA and proteins from Fenton's reagent-induced o

44 onfocal live cell imaging, we show that both plasmid DNA and siRNA are internalised via endocytosis.

45 ipathic histidine rich peptides possess high plasmid DNA and siRNA delivery capabilities.

46 homatis mouse pneumonitis (MoPn) genomic and plasmid DNA and tested it with serum samples from MoPn-i

47 Heterologous prime-boost immunization with plasmid DNA and viral vector vaccines is an emerging app

48 M-LMNs loaded with plasmid DNA and/or doxorubicin are efficiently taken up

49 h viral genomes, binds to incoming viral and plasmid DNAs and deposits histone H3.3 onto these.

50 ong double-stranded DNAs, including circular plasmid DNAs and genomic DNAs.

51 We transfected various source cells with plasmid DNAs and stimulated the cells with a focal and t

52 , were susceptible to the virus rescued from plasmid DNAs and supported production of the virus over

53 oduce recombinant products such as proteins, plasmid DNAs and vaccines.

54 es were evaluated using combinations of both plasmid-DNA and transposase-protein relocalization to th

55 s, germline transgenesis, electroporation of plasmid DNA, and microinjection of morpholinos are all r

56 he NPC1(-/-) null mouse, and delivery of the plasmid DNA, and NPC1 mRNA expression in brain, spleen,

57 es not affect the biological activity of the plasmid DNA, and that the core-shell formulations have n

58 In mouse T cells, cGAS KO ablated sensing of plasmid DNA, and TREX1 KO enabled cells to sense short i

59 The present work develops a plasmid DNA approach to gene therapy of NPC1 using Troja

60 Possible roles for Sub1 proteins in NHEJ of plasmid DNA are discussed.

61 of redox control observed for lipoplexes of plasmid DNA are maintained in complexes formed using sma

62 cal assays based on Cre-mediated knotting of plasmid DNAs are consistent with a right-handed chiral j

63 Here, we describe the use of plasmid DNA as a stable, robust and configurable scaffol

64 Monofunctional pyriplatin reacted with plasmid DNA as efficiently as bifunctional cisplatin and

65 , we tested a different formulation in which plasmid DNA associates with the surface of preformed 20-

66 human and canine cells partition transfected plasmid DNA asymmetrically, preferentially into the daug

67 lasmid release from the complex and so limit plasmid DNA availability.

68 necessary to orchestrate the propagation of plasmid DNA between bacterial cells through conjugative

69 with spiky surfaces demonstrate the highest plasmid DNA binding capability and transfection efficacy

70 , BALB/c mice were given three injections of plasmid DNA-Bla g 1 prior to sensitization with two prim

71 y enhanced bone regeneration compared to PEI-plasmid DNA (BMP-2)-activated matrices.

72 SUB1 is required for NHEJ repair of DSBs in plasmid DNA, but not in chromosomal DNA.

73 h cisplatin enhances double-strand breaks of plasmid DNA by a factor of approximately 3.5 and dramati

74 rt that (-)-lomaiviticin A nicks and cleaves plasmid DNA by a pathway that is independent of reactive

75 nwinding of both linear and natural circular plasmid DNA by PcrA/RepD was followed in real-time using

76 delivery via simultaneous administration of plasmid DNA by the i.m. and i.d. routes.

77 he type IV REase in restricting 5mC-modified plasmid DNA by transformation into clinical S. aureus st

78 4(+) T cells expressed cGAS and responded to plasmid DNA by upregulation of ISGs and release of bioac

79 We found that site-specific mutations in plasmid DNA can be generated in Escherichia coli using m

80 Sufficient plasmid DNA can be isolated from 100 ml E. coli cultures

81 The uncut plasmid DNA can be used for transfection if the sole pur

82 le-mediated transcutaneous immunization with plasmid DNA can potentially induce a stronger immune res

83 e screening, rolling circle amplification of plasmid DNA, capillary electrophoresis and automated dig

84 SB100X hyperactive transposase together with plasmid DNA carrying a transgene construct flanked by bi

85 eractive transposase, together with circular plasmid DNA carrying a transgene construct flanked by bi

86 This study examines the fate of plasmid DNA carrying ampicillin and tetracycline resista

87 Stable transfection of HEK-293T cells with plasmid DNA carrying EqCXCL16 (HEK-EqCXCL16 cells) incre

88 measurements of a model system of clustered plasmid-DNA centered by the dynamically unstable actin-l

89 AS-dependent cell-intrinsic response to both plasmid DNA challenge or inoculation with HSV-1DeltaUL41

90 5GHPV3 was delivered by plasmid DNA, chimpanzee adenovirus (ChAdOx1) and modifie

91 Mini plasmid DNA circles with three or five operators positio

92 licited a stronger immune response than with plasmid DNA-coated net negatively charged nanoparticles

93 Transcutaneous immunization with plasmid DNA-coated net positively charged nanoparticles

94 Transcutaneous immunization with plasmid DNA-coated net positively charged nanoparticles

95 rticles are composed of a single molecule of plasmid DNA compacted with block copolymers of poly-L-ly

96 noparticles, composed of single molecules of plasmid DNA compacted with block copolymers of poly-l-ly

97 linked to itself interacts differently with plasmid DNA compared to conventional vectors and when te

98 hese data demonstrate that mucosally applied plasmid DNA complexed to PEI followed by a mucosal prote

99 Significant differences in behavior toward plasmid DNA condensation are correlated with biological

100 mplates (synthesized linear dsDNA and cloned plasmid DNA constructs).

101 ional non-viral gene transfer uses bacterial plasmid DNA containing antibiotic resistance genes, cis-

102 say using mammalian cell nuclear extract and plasmid DNA containing bulky adducts formed by N-acetoxy

103 as they require embryos to be injected with plasmid DNA containing the exon tag.

104 thin the procapsid and recircularizes linear plasmid DNA containing two terminal loxP recognition sit

105 g poly beta-amino ester (PBAE) polymers with plasmid DNAs containing a GFP reporter gene.

106 cted nucleosome positioning in vitro on four plasmid DNAs containing DNA fragments derived from the g

107 ceptor-targeted, DNA-binding peptide (P) and plasmid DNA (D), which electrostatically self-assembled

108 We monitored plasmid DNA degradation using gel electrophoresis and qP

109 We have demonstrated efficient plasmid DNA delivery into intact plants of several speci

110 When combined with amphipathic peptide-based plasmid DNA delivery, these bioinks supported enhanced n

111 MCF-7 and A549 cells and compared this with plasmid DNA delivery.

112 iption-coupled hypernegative supercoiling of plasmid DNA did not need the expression of a membrane-in

113 ither as double-stranded RNA (dsRNA) or RNAi plasmid DNA (dsDNA).

114 o centrosomes together bias the partition of plasmid DNA during mitosis.

115 demonstrate how high-speed AFM can visualize plasmid DNA dynamics, intermittent nucleosome-nucleosome

116 Importantly, use of plasmid DNA enabled lower depth sequencing, and assembli

117 Plasmid DNA-encoded anti-OspA HuMAbs inoculated in mice

118 strate co-delivery of luciferase protein and plasmid DNA encoding a fluorescent protein from two diff

119 BALB/c mice were immunized i.m. with plasmid DNA encoding a model Ag HIV-1 Env gp140 and sele

120 We utilized two kinds of plasmid DNA encoding either BMP-2 or FGF-2 formulated in

121 ing a natural phenomenon observed in tumors, plasmid DNA encoding for a soluble ligand to NKG2D (sRAE

122 ity and eTE were systematically explored for plasmid DNA encoding green fluorescent protein following

123 , we administered intracranial injections of plasmid DNA encoding IL-10 (pDNA-IL-10) into the NAc of

124 e prepared via freeze drying and loaded with plasmid DNA encoding perlecan domain I and VEGF189 and a

125 The plasmid DNA encoding perlecan domain I and VEGF189 loade

126 d-calcium-phosphate nanoparticles to deliver plasmid DNA encoding RLN.

127 umor immunity induced upon immunization with plasmid DNA encoding SV40 Tag as a transgene (pCMV-Tag).

128 THLs were encapsulated with a 8.0 kb plasmid DNA encoding the 3.9 kb human NPC1 open reading

129 mia that hydrodynamic tail-vein injection of plasmid DNA encoding the adenine base editor (ABE) and a

130 Lung delivery of plasmid DNA encoding the CFTR gene complexed with a cati

131 By sequentially immunizing mice with plasmid DNA encoding the hemagglutinin of antigenically

132 we inoculated nonhuman primates (NHPs) with plasmid DNA encoding transmembrane-anchored, cleaved JRF

133 s suggest that chitosan scaffolds containing plasmid DNA encoding VEGF189 and perlecan domain I have

134 Two groups were primed with plasmid DNAs encoding the secreted form of glycoprotein

135 arisons with PEI complexed with conventional plasmid DNA (encoding BMP-2).

136 UvrC from Mtb collectively bound and cleaved plasmid DNA exposed to ultraviolet (UV) irradiation or p

137 d hydrodynamic injection to deliver a CRISPR plasmid DNA expressing Cas9 and single guide RNAs (sgRNA

138 li (E coli) containing plasmids, followed by plasmid DNA extraction and purification prior to downstr

139 uine IgG obtained from horses immunized with plasmid DNA followed by boosting with Kunjin replicon vi

140 ecifically evaluated the advantages of using plasmid DNA for sequencing and the value of supplementin

141 can be genetically programmed with nonviral plasmid DNA for the biogenesis and delivery of antisense

142 ation of parasites in a sample, we developed plasmid DNAs for all the three assay targets for absolut

143 We show that peptide efficiently packaged plasmid DNA forming spherical, highly cationic nanocompl

144 i, such as by insertion of foreign (viral or plasmid) DNA fragments into clustered regularly interspa

145 NA method was employed for the extraction of plasmid DNA from bacterial cell lysate.

146 ve B. burgdorferi much more efficiently than plasmid DNA from E. coli, particularly when the bbe02 an

147 rBCP was also found to protect supercoiled plasmid DNA from oxidative damage (i.e., nicking) in vit

148 or CMV, or transient transfection with naked plasmid DNA, HIRA re-localizes to PML bodies, sites of c

149 sp and Imu1-3 and examined their activity on plasmid DNA, human umbilical vein endothelial cells, and

150 persistent transgene expression compared to plasmid DNA in a number of organ systems but has not bee

151 urface chemistries optimized for delivery of plasmid DNA in a plant species-independent manner.

152 study demonstrates for the first time use of plasmid DNA in absolute quantification of malaria parasi

153 ors/Z-DNA binding protein 1 (DAI/ZBP1) bound plasmid DNA in the cytosol within 15 minutes of transfec

154 Polyphenols extracted from honeys degraded plasmid DNA in the presence of H2O2 and Cu(II) in the Fe

155 on of HPV-11, -16, and -18 origin-containing plasmid DNA in transfected cells at concentrations well

156 n this study we compared minicircle DNA with plasmid DNA in transfections of airway epithelial cells.

157 transfection of luciferase and GFP reporter plasmid DNA in vitro and in vivo under various condition

158 urination mediated by cruciform formation in plasmid DNA in vitro.

159 reconstituted pre-RCs support replication of plasmid DNA in yeast cell extracts in a reaction that ex

160 Our results elucidate the evolution of plasmid DNAs in red algae and suggest that they spread a

161 Plasmid DNA incubated in aged urine resulted in a >2 log

162 mbinase (ZFR) fusion proteins that integrate plasmid DNA into a synthetic target site in the human ge

163 ng protein that targets chromosomes, carries plasmid DNA into cells, and shows specificity for active

164 ow efficient delivery of biologically active plasmid DNA into CHO-K1 cells.

165 First, they transport plasmid DNA into Escherichia coli about 2-fold over cont

166 used to directly catalyze the integration of plasmid DNA into mammalian genomes, there is still an un

167 The cationic Man-CS-Phe micelles condense plasmid DNA into nanoscale polyplexes and provide effici

168 This material effectively condenses plasmid DNA into salt-stable particles that deshield und

169 ped two polymeric gene carriers that compact plasmid DNA into small and highly stable nanoparticles w

170 IFI16 also restricted the expression of plasmid DNAs introduced by transfection but did not rest

171 n-induced single-strand-break (SSB) yield in plasmid DNA involves measurement of the fraction of rela

172 Although plasmid DNA is a promising tool bearing the unique poten

173 Plasmid DNA is a promising vaccine platform that togethe

174 When the input is on, plasmid DNA is degraded 10(8)-fold.

175 g Trojan horse liposomes (THLs), wherein the plasmid DNA is encapsulated in 100 nm pegylated liposome

176 Circular carrier plasmid DNA is included during subsequent DNA purificati

177 Conjugation, the process by which plasmid DNA is transferred from one bacterium to another

178 orbent surface leads to full recovery of all plasmid DNA isoforms, which is a major issue when using

179 d, with the best-performing model applied to plasmid DNA isolated from Escherichia coli and mitochond

180 is co-transfected with transposon-containing plasmid DNA, it penetrates prokaryotic or eukaryotic cel

181 improves microparticle-based transfection of plasmid DNA lipoplexes in several primary human cell typ

182 antly enhanced survival compared to the same plasmid DNA loaded in DNA-CN in two aggressive orthotopi

183 imine (PEI)-functionalized SWNTs and perform plasmid DNA loading.

184 uciferase reporter gene) to form a liposomal-plasmid DNA (LpDNA) complex.

185 Plasmid DNA may exist in three isoforms, the linear, ope

186 e prophylactic and therapeutic efficacy of a plasmid DNA-mediated vaccination using the Bla g 1 gene

187 g multiple DNA nanostructures as well as two plasmid DNAs, microwaves were shown to promote the repai

188 ptide with a nucleic acid binding domain and plasmid-DNA, minicircle-DNA or small interfering RNA (si

189 To maximize cytokine production from plasmid DNA, molecular steps controlling IL-12p70 biosyn

190 Each plasmid DNA molecule encodes many origins of synthesis.

191 ata demonstrated that the mean SSB yield per plasmid DNA molecule of [21.2+/-0.59]x10(-2)Gy(-1) as me

192 oscopy confirmed that mouse PPy/u containing-plasmid DNA molecules under the different structural str

193 Plasmid DNA molecules with unique loop structures have w

194 -DNA nanoparticles are capable of delivering plasmid DNA of different size into cells in culture, yie

195 imultaneous delivery of siRNA and linearized plasmid DNA on the surface of a single nanocrystal provi

196 s were significantly enhanced by coating the plasmid DNA on the surface of cationic nanoparticles.

197 d by transcutaneous immunization by applying plasmid DNA onto a skin area pretreated with solid micro

198 that transcutaneous immunization by applying plasmid DNA onto a skin area wherein the hair follicles

199 idazoles do not cause nicking of supercoiled plasmid DNA or cleavage of bovine serum albumin.

200 ies, phiC31 integrase has been introduced as plasmid DNA or mRNA.

201 ys, the transfected cell microarray, wherein plasmid DNA or siRNA, spotted on the surface of a substr

202 o this include making use of vectors such as plasmid DNA or viruses, live attenuated pathogens or sub

203 ved ORF analyses showed that the majority of plasmid DNAs originated within red algae, whereas others

204 Furthermore, sinapine provided plasmid DNA (pBR322) protection, from 2,2'-azobis(2-amid

205 ession in recipient cells resulted only from plasmid DNA (pDNA) after delivery via MVs.

206 Commutability of plasmid DNA (pDNA) and genomic DNA (gDNA) calibrators fo

207 dermal administration of nucleic acids, both plasmid DNA (pDNA) and siRNA, to treat localised disease

208 ic polyamine disulfides to condense and cage plasmid DNA (pDNA) by a process of thermodynamically con

209 on of macrophages transfected ex vivo with a plasmid DNA (pDNA) encoding a potent antioxidant enzyme,

210 Oral administration of the plasmid DNA (pDNA) encoding GLP-1 decreased diabetic glu

211 The developed plasmid DNA (pDNA) individually produced both IAPP and L

212 ers were characterized for size, morphology, plasmid DNA (pDNA) loading and surface charge.

213 roxyethyl acrylate that effectively compacts plasmid DNA (pDNA) through electrostatic binding and int

214 Electroporation (EP) for plasmid DNA (pDNA) vaccine delivery has demonstrated the

215 HIV-derived conserved element (CE) p24(gag) plasmid DNA (pDNA) vaccine is able to redirect immunodom

216 ase or angiotensin II type 2 receptor (AT2R) plasmid DNA (pDNA) was evaluated in Lewis lung carcinoma

217 EGFP messenger RNA (mRNA) and GFP plasmid DNA (pDNA) were used as reporter genes to evalua

218 dle delivery of nucleic acids, in particular plasmid DNA (pDNA), to the skin represents a potential n

219 ransfection of several tumor cell types with plasmid DNA (pDNA).

220 in which the liposomes are designed to carry plasmid DNA (pDNA, containing luciferase reporter gene)

221 subcutaneous injection of cationized gelatin/plasmid DNA polyplex into the rat hindpaw and its subseq

222 We detected adenine methylation of plasmid DNA prepared from B. burgdorferi that carried bb

223 Here we immunized rhesus monkeys by plasmid DNA prime and recombinant vaccinia virus boost w

224 e the transfection efficiency of GFP-encoded plasmid DNA (pRmHa3-GFP) into cells through efficient DN

225 Finally, DNA-BPN loaded with anti-cancer plasmid DNA provided significantly enhanced survival com

226 However, plasmid DNA purified from B. burgdorferi transformed nai

227 l groups were primed with the empty backbone plasmid DNA (pVAX).

228 Indeed, we show that CN enhances plasmid DNA relaxation due to Fenton's reaction in vitro

229 s more potent than deglycoBLM in supercoiled plasmid DNA relaxation, while the analogue having the di

230 d Pif1 are also important for termination of plasmid DNA replication in vivo.

231 imilar are not equivalent and that repair of plasmid DNA requires additional factor(s) that are not r

232 Plasmid DNA sequencing of previously uncharacterized cli

233 ry system can be extended to the delivery of plasmid DNA, siRNA, or aptamers for preclinical and clin

234 used different formulations of a linearized plasmid DNA solution considered for characterization as

235 1 muL droplet of whole blood, and we amplify plasmid DNA spiked into whole blood droplets to represen

236 Furthermore, the efficient amplification of plasmid DNA spiked into whole blood proves that the larg

237 The use of plasmid DNA standard in quantification of malaria parasi

238 A recent publication showed that circular plasmid DNA standards grossly overestimated numbers of a

239 ed LDL-cholesterol oxidation and supercoiled plasmid DNA strand breakage inhibition induced by both p

240 nstitution of the VSP repair pathway using a plasmid DNA substrate.

241 as both MeC and C nucleobases in transfected plasmid DNA substrates are highly susceptible to editing

242 transform plants by transferring a region of plasmid DNA, T-DNA, into host plant cells.

243 The Sso-IIID complex can cleave plasmid DNA targets in vitro, generating linear DNA prod

244 n the successful construction of a series of plasmid DNA templates that contain many tandem copies of

245 a procedure for the isolation of total rumen plasmid DNA, termed rumen plasmidome, and subjected it t

246 Here we describe an iDNA vaccine composed of plasmid DNA that encode the full-length infectious genom

247 demonstrated superior condensing ability for plasmid DNA through the formation of compact nanosized p

248 al and liposomal vectors for the delivery of plasmid DNA to cells for gene therapy applications.

249 -walled carbon nanotubes selectively deliver plasmid DNA to chloroplasts of different plant species w

250 mycobacteria, and to prevent segregation of plasmid DNA to daughter cells.

251 nanocarrier is found to effectively condense plasmid DNA to form a highly stable GNR-DSPEI-PEG-RGD/DN

252 expression, via liposomal delivery of Foxm1 plasmid DNA to Hif1a(f/f)/Tie2Cre(+) mice, resulted in r

253 ionalized fluorescent probes, antibodies, or plasmid DNA to living cells requires overcoming the plas

254 (DAB) dendrimer would allow the transport of plasmid DNA to the brain after intravenous administratio

255 imine dendrimer would allow the transport of plasmid DNA to the brain after intravenous administratio

256 eplicative relaxase and directly targets the plasmid DNA to the ICEBs1 conjugation apparatus.

257 The delivery of plasmid DNA to the skin can target distinct subsets of d

258 f PEI can be effective delivery vehicles for plasmid DNAs to elicit cellular and humoral protective r

259 ut, contributing to a 2.5~3 fold increase on plasmid DNA transfection and an additional 10-55% transg

260 Using HIV-lentivector and plasmid DNA transfection, we also developed A2A and A2B

261 s for gene therapy of airway disorders where plasmid DNA transfections have so far proven inefficient

262 One requires NHEJ of linearized plasmid DNA transformed into the test organism; the othe

263 Unlike T4CPs involved in plasmid DNA translocation, DotL appeared to function by

264 ase of the bacterium (OD 6.0) using 25 ng of plasmid DNA under 100 Ohms resistance and 1.7 kV/cm volt

265 Here, we visualize plasmid DNA unwinding and binding dynamics to an oligonu

266 ounds exhibited significant photocleavage of plasmid DNA upon visible light irradiation and are rapid

267 ) and microRNA-125b-2 (miR-125b2) expressing plasmid DNA using hyaluronic acid-poly(ethylene imine)/h

268 The 6-plasmid DNA vaccine (expressing clade B Gag, Pol, and Ne

269 A plasmid DNA vaccine and a single-shot recombinant rhesus

270 an influenza challenge model we show that a plasmid DNA vaccine complexed to a less toxic form of PE

271 vatives of PEI could be utilised for topical plasmid DNA vaccine delivery to human mucosal tissue sur

272 Encapsulation of plasmid DNA vaccine expressing IBV nucleocapsid (N) prot

273 IV-1 CN54gp140 antigen when cation-complexed plasmid DNA vaccines are applied topically to the murine

274 Plasmid DNA vaccines encoding the fusion genes generated

275 A plasmid DNA vector coding for the Bla g 1 allergen contr

276 te nanotopography of silica nanoparticles as plasmid DNA vectors has significant impact on the transf

277 Efficient in vitro electrotransfection of plasmid DNA was demonstrated in several hard-to-transfec

278 One copy of plasmid DNA was established to be equivalent to 0.1 para

279 Detection of HPV type-specific plasmid DNA was highly specific, with high signal-to-noi

280 When the plasmid DNA was incubated in aged urine that had been fi

281 Plasmid DNA was not detectably bound by DEAD box helicas

282 The gel assay, which used supercoiled plasmid DNA, was sensitive to both SSBs and DSBs.

283 led to a luciferase bioluminescence reporter plasmid DNA were shown to transfect tumors implanted in

284 and the mobilities of circular versus linear plasmid DNAs were also affected by the chemical form and

285 are incorporated into cells or organisms as plasmid DNA, which leads the transcriptional and transla

286 sition of horizontally transferred phage and plasmid DNA, which provides virulence and resistance fun

287 an be derived from biologically synthesized (plasmid) DNA, which reduces errors associated with chemi

288 rR links the filaments with centromeric parC plasmid DNA, while facilitating the addition of subunits

289 anostructures and single-stranded regions of plasmid DNA, while intense THz pulses had the opposite e

290 (TopA67) but not full-TopA in the absence of plasmid DNA, while PrS-YjhX binds to full-TopA in the pr

291 orphologies are prepared via condensation of plasmid DNA with a block copolymer of polyethylene glyco

292 videnced by up to 16% recovery of the spiked plasmid DNA with a pore size of 0.2 mum.

293 rform multiple displacement amplification of plasmid DNA with a very low error rate.

294 ting stem-loop was confirmed by digestion of plasmid DNA with apurinic endonuclease IV, followed by p

295 Tth111II cleaves a two-site plasmid DNA with equal efficiency regardless of site ori

296 , and large fragments (>3000 bp) of digested plasmid DNA with good efficacy.

297 Treatment of plasmid DNA with H2O2 alone did not affect the DNA integ

298 nd simple system for delivering oncolytic Ad plasmid DNA with the bioreducible polymers, skipping tim

299 nthetic nanonucleases, able to cleave pBR322 plasmid DNA with the highest efficiency reported so far

300 developed a novel system using oncolytic Ad plasmid DNA with two bioreducible polymers: arginine-gra